John L. Higgins

2015

In 2015, John L. Higgins earned a total compensation of $4.6M as Chief Executive Officer at Ligand Pharmaceuticals, a 25% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$392,029
Option Awards$1,810,851
Salary$547,336
Stock Awards$1,794,131
Other$6,369
Total$4,550,716

Higgins received $1.8M in option awards, accounting for 40% of the total pay in 2015.

Higgins also received $392K in non-equity incentive plan, $547.3K in salary, $1.8M in stock awards and $6.4K in other compensation.

Rankings

In 2015, John L. Higgins' compensation ranked 1,826th out of 13,638 executives tracked by ExecPay. In other words, Higgins earned more than 86.6% of executives.

ClassificationRankingPercentile
All
1,826
out of 13,638
87th
Division
Manufacturing
660
out of 5,187
87th
Major group
Chemicals And Allied Products
242
out of 1,857
87th
Industry group
Drugs
188
out of 1,531
88th
Industry
Pharmaceutical Preparations
151
out of 1,179
87th
Source: SEC filing on April 14, 2017.

Higgins' colleagues

We found five more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2015.

2015

Matthew Foehr

Ligand Pharmaceuticals

Chief Operating Officer

2015

Matthew Korenberg

Ligand Pharmaceuticals

Chief Financial Officer

2015

Nishan de Silva

Ligand Pharmaceuticals

Chief Financial Officer

2015

Charles Berkman

Ligand Pharmaceuticals

General Counsel

2015

Melanie Herman

Ligand Pharmaceuticals

Chief Financial Officer

News

You may also like